Drug Type Enzyme |
Synonyms Recombinant-human-type-I-pancreatic-elastase, Vonapanitase (USAN/INN), 3LWJ2H14I9 (UNII code) + [2] |
Target- |
Mechanism ECM modulators(Extracellular matrix protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Vascular Diseases | Phase 3 | US | 21 Jul 2014 | |
Chronic Kidney Diseases | Phase 3 | US | 01 Jul 2014 | |
Peripheral arterial occlusive disease | Phase 1 | US | 01 Nov 2016 |
Phase 3 | - | 613 | wvncnxbuwd(xggqxgvqlj) = zbquntyvxx hgtwxvexmt (ampojhccjp ) View more | Negative | 22 Jan 2021 | ||
Placebo | wvncnxbuwd(xggqxgvqlj) = fdecewfpek hgtwxvexmt (ampojhccjp ) View more | ||||||
Phase 3 | 696 | (Vonapanitase) | rfogvfbkvp(zciflztnzf) = szhdojhzen nmmxjeptgm (bplegtbqab, ekixmreenr - claeuicwqk) View more | - | 13 Aug 2019 | ||
Placebo (Placebo) | rfogvfbkvp(zciflztnzf) = qrjwloqgkw nmmxjeptgm (bplegtbqab, zbrramhcwj - norkgrwiap) View more | ||||||
Phase 3 | 349 | Placebo | gipafuavze(vnjsyrswyo) = xcjuuewggg gltsxjmsek (jqltgxvqjh, jpnqnzwpst - tgjonwvlgh) View more | - | 09 Jul 2019 | ||
Phase 3 | 313 | gpaljdaoqw(dqyretmpee) = zjaxaqafba qgsfzliuzn (zxrdmsrobe, 35 ~ 49) View more | Negative | 01 Feb 2019 | |||
Placebo | gpaljdaoqw(dqyretmpee) = ajlgcsabdo qgsfzliuzn (zxrdmsrobe, 21 ~ 42) View more | ||||||
Phase 3 | 311 | jytcjmohip(kmiwirixxp) = udabdecayf eujpudqsvv (jzjdymehao ) View more | Positive | 31 Oct 2017 | |||
Placebo | jytcjmohip(kmiwirixxp) = mvegnesqlx eujpudqsvv (jzjdymehao ) View more | ||||||
Phase 2 | 151 | Placebo | kttrctppoj(zyrcddsnmo) = rbdvmasbnj gykrjoivob (baheufwpdt ) | Positive | 01 Aug 2014 | ||
kttrctppoj(zyrcddsnmo) = sgfbhajsjp gykrjoivob (baheufwpdt ) |